Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3865 Neoplasms 2990 Prostatic Neoplasms 1754 Colorectal Neoplasms 1431 Lung Neoplasms 1331 Motor Activity 805 Head and Neck Neoplasms 686 Pancreatic Neoplasms 663 Colonic Neoplasms 655 Uterine Cervical Neoplasms 653 Carcinoma, Hepatocellular 632 Carcinoma, Non-Small-Cell Lung 631 Rectal Neoplasms 571 Stomach Neoplasms 547 Brain Neoplasms 486 Ovarian Neoplasms 441 Anxiety Disorders 420 Pain 419 Neoplasm Metastasis 385 Esophageal Neoplasms 384 Polycystic Ovary Syndrome 376 Precursor Cell Lymphoblastic Leukemia-Lymphoma 354 Urinary Bladder Neoplasms 351 Fatigue 340 Melanoma 323 Multiple Myeloma 322 Lymphoma 306 Depression 306 Endometrial Neoplasms 290 Liver Neoplasms 280

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Interventional × Primary Care × Clear all

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡